8th German Pharm-Tox Summit

Profiling changes in the cancer HLA-I peptide repertoire upon pharmacological intervention with kinase inhibitors and epigenetic modifiers

Cancer pharmacology	

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Andreas Schlosser

Further involvements